Showing results (1701-1710 of 6,943) with videos related to
Sort By:
Pageof 695
Cancer Science|June 14, 2022
Antitumoral RNA-targeted oligonucleotide therapeutics: The third pillar after small molecule inhibitors and antibodiesHiroaki Taniguchi, Yasunori Suzuki, Kohzoh Imai, et al.Cancer Science|June 14, 2022
RITA1 drives the growth of bladder cancer cells by recruiting TRIM25 to facilitate the proteasomal degradation of RBPJHuancheng Tang, Xiangdong Li, Lijuan Jiang, et al.Cancer Science|January 29, 2011
Curcumin analog GO-Y030 is a novel inhibitor of IKKβ that suppresses NF-κB signaling and induces apoptosisAtsuko Sato, Chieko Kudo, Hiroyuki Yamakoshi, et al.Cancer Science|January 29, 2011
Efficacy of gefitinib for non-adenocarcinoma non-small-cell lung cancer patients harboring epidermal growth factor receptor mutations: a pooled analysis of published reportsTakehito Shukuya, Toshiaki Takahashi, Rieko Kaira, et al.Cancer Science|January 29, 2011
Carboxyl terminus of Hsp70-interacting protein (CHIP) contributes to human glioma oncogenesisTao Xu, Quan Zhou, Jingxu Zhou, et al.Cancer Science|January 29, 2011
c-Jun N-terminal kinase activation by oxidative stress suppresses retinoid signaling through proteasomal degradation of retinoic acid receptor α protein in hepatic cellsYoshiko Hoshikawa, Keita Kanki, An Afida Ashla, et al.Cancer Science|December 16, 2010
EGFR overexpression induces activation of telomerase via PI3K/AKT-mediated phosphorylation and transcriptional regulation through Hif1-alpha in a cellular model of oral-esophageal carcinogenesisSteffen Heeg, Nina Hirt, Angela Queisser, et al.Cancer Science|December 16, 2010
Relevance of monitoring metabolic reduction in patients with relapsed or refractory follicular and mantle cell lymphoma receiving bendamustine: a multicenter studyUkihide Tateishi, Mitsuaki Tatsumi, Takashi Terauchi, et al.Cancer Science|January 6, 2011
Metronomic irinotecan chemotherapy combined with ultrasound irradiation for a human uterine sarcoma xenograftBatsuren Choijamts, Yasuko Naganuma, Kyoko Nakajima, et al.Cancer Science|January 6, 2011
The in vitro and in vivo anti-tumor effect of KO-202125, a sauristolactam derivative, as a novel epidermal growth factor receptor inhibitor in human breast cancerMiyun Oh, Jeong-Yeon Lee, Dong-Hui Shin, et al.Pageof 695